Prospective, multicentre, open label, clinical study to evaluate efficacy and safety of R-TPR-011 in patients with multiple sclerosis.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Interferon beta (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Reliance Life Sciences
- 15 Mar 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 07 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 11 Feb 2010 New trial record